ZBH
Zimmer Biomet Holdings, Inc. NYSE Listed Jul 25, 2001$87.16
-2.43%
vs $89.33
Mkt Cap $17.3B
52w Low $79.58
26.9% of range
52w High $107.71
50d MA $87.15
200d MA $92.60
P/E (TTM)
24.6x
EV/EBITDA
10.7x
P/B
1.4x
Debt/Equity
0.6x
ROE
5.5%
P/FCF
11.8x
RSI (14)
68.00
ATR (14)
$2.12
Beta
0.61
50d MA
$87.15
200d MA
$92.60
Avg Volume
2.2M
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as robotic, surgical and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
345 East Main Street · Warsaw, IN 46580 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 28, 2026 | TNS | 1.86 | 2.09 | +12.4% | 82.80 | -0.9% | -3.3% | +2.9% | +0.6% | -0.3% | +0.5% | — |
| Feb 10, 2026 | TNS | 2.38 | 2.42 | +1.7% | 91.40 | -0.6% | +4.6% | -0.4% | +1.3% | +0.7% | +1.1% | — |
| Nov 5, 2025 | TNS | 1.87 | 1.90 | +1.6% | 87.55 | -1.7% | +1.1% | -0.0% | +0.3% | -0.3% | +1.7% | — |
| Aug 7, 2025 | TNS | 1.98 | 2.07 | +4.5% | 98.43 | +0.6% | +0.8% | +0.8% | +1.8% | +1.4% | -1.1% | — |
| May 5, 2025 | TNS | 1.77 | 1.81 | +2.3% | 90.48 | +0.0% | +2.0% | +2.0% | +1.0% | +0.1% | +3.2% | — |
| Feb 6, 2025 | TNS | 2.30 | 2.31 | +0.4% | 102.69 | +0.2% | -1.7% | -0.5% | -1.4% | +0.0% | +0.9% | — |
| Oct 30, 2024 | TNS | 1.74 | 1.74 | +0.0% | 109.81 | -0.1% | -2.6% | +0.3% | +1.1% | +0.5% | +1.1% | — |
| Aug 7, 2024 | TNS | 1.99 | 2.01 | +1.0% | 105.81 | +0.2% | +2.7% | -0.6% | -1.0% | +2.2% | -0.6% | — |
| May 2, 2024 | TNS | 1.87 | 1.94 | +3.7% | 118.46 | +0.9% | +2.7% | -0.9% | +0.7% | -0.5% | +0.5% | — |
| Feb 8, 2024 | TNS | 2.15 | 2.20 | +2.3% | 123.04 | +0.7% | -0.2% | +2.5% | -2.1% | -1.1% | +2.1% | — |
| Nov 7, 2023 | TNS | 1.59 | 1.65 | +3.8% | 105.93 | +0.0% | -1.0% | -0.7% | +1.2% | +0.4% | +2.1% | — |
| Aug 1, 2023 | TNS | 1.82 | 1.82 | +0.0% | 132.27 | -0.4% | -2.9% | -2.0% | +0.4% | -0.5% | -0.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 29 | Citigroup | Maintains | Neutral → Neutral | — | $82.80 | $82.03 | -0.9% | -3.3% | +2.9% | +0.6% | -0.3% | +0.4% |
| Apr 29 | JP Morgan | Maintains | Neutral → Neutral | — | $82.80 | $82.03 | -0.9% | -3.3% | +2.9% | +0.6% | -0.3% | +0.4% |
| Apr 29 | Truist | Maintains | Hold → Hold | — | $82.80 | $82.03 | -0.9% | -3.3% | +2.9% | +0.6% | -0.3% | +0.4% |
| Apr 29 | Citizens | Maintains | Market Outperform → Market Outperform | — | $82.80 | $82.03 | -0.9% | -3.3% | +2.9% | +0.6% | -0.3% | +0.4% |
| Apr 29 | Stifel | Maintains | Buy → Buy | — | $82.80 | $82.03 | -0.9% | -3.3% | +2.9% | +0.6% | -0.3% | +0.4% |
| Apr 29 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $82.80 | $82.03 | -0.9% | -3.3% | +2.9% | +0.6% | -0.3% | +0.4% |
| Apr 29 | Barclays | Maintains | Underweight → Underweight | — | $82.80 | $82.03 | -0.9% | -3.3% | +2.9% | +0.6% | -0.3% | +0.4% |
| Mar 23 | BTIG | Downgrade | Buy → Neutral | — | $87.87 | $88.73 | +1.0% | -0.1% | -1.7% | +1.5% | +1.7% | -0.7% |
| Feb 12 | Barclays | Maintains | Underweight → Underweight | — | $95.61 | $95.55 | -0.1% | -0.4% | +1.3% | +0.7% | +1.1% | +1.0% |
| Feb 11 | Citigroup | Maintains | Neutral → Neutral | — | $91.40 | $90.87 | -0.6% | +4.6% | -0.4% | +1.3% | +0.7% | +1.1% |
| Feb 11 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $91.40 | $90.87 | -0.6% | +4.6% | -0.4% | +1.3% | +0.7% | +1.1% |
| Feb 10 | BTIG | Maintains | Buy → Buy | — | $89.73 | $94.15 | +4.9% | +1.9% | +4.6% | -0.4% | +1.3% | +0.7% |
| Feb 10 | Needham | Maintains | Hold → Hold | — | $89.73 | $94.15 | +4.9% | +1.9% | +4.6% | -0.4% | +1.3% | +0.7% |
| Jan 28 | UBS | Maintains | Sell → Sell | — | $85.99 | $85.40 | -0.7% | -0.3% | +0.4% | +1.2% | -1.0% | -0.0% |
| Jan 9 | Bernstein | Maintains | Market Perform → Market Perform | — | $94.08 | $92.99 | -1.2% | -1.3% | -1.5% | -3.4% | +1.0% | -0.5% |
| Jan 8 | BTIG | Maintains | Buy → Buy | — | $92.67 | $91.94 | -0.8% | +1.5% | -1.3% | -1.5% | -3.4% | +1.0% |
| Jan 5 | Evercore ISI | Upgrade | In Line → Outperform | — | $90.02 | $90.27 | +0.3% | +2.9% | +2.3% | -2.2% | +1.5% | -1.3% |
| Dec 16 | Baird | Downgrade | Outperform → Neutral | — | $92.43 | $92.01 | -0.5% | -1.6% | +0.7% | -1.3% | -1.4% | +0.8% |
| Dec 11 | Citigroup | Maintains | Neutral → Neutral | — | $93.09 | $93.00 | -0.1% | -0.7% | -0.9% | +0.9% | -1.6% | +0.7% |
| Nov 10 | Canaccord Genuity | Maintains | Hold → Hold | — | $88.50 | $87.96 | -0.6% | +0.3% | -0.3% | +1.7% | +0.6% | -0.7% |
| Nov 6 | RBC Capital | Maintains | Outperform → Outperform | — | $87.55 | $86.07 | -1.7% | +1.1% | -0.0% | +0.3% | -0.3% | +1.7% |
| Nov 6 | Barclays | Maintains | Underweight → Underweight | — | $87.55 | $86.07 | -1.7% | +1.1% | -0.0% | +0.3% | -0.3% | +1.7% |
| Nov 6 | UBS | Maintains | Sell → Sell | — | $87.55 | $86.07 | -1.7% | +1.1% | -0.0% | +0.3% | -0.3% | +1.7% |
| Nov 6 | JP Morgan | Downgrade | Overweight → Neutral | — | $87.55 | $86.07 | -1.7% | +1.1% | -0.0% | +0.3% | -0.3% | +1.7% |
| Nov 5 | Barclays | Maintains | Underweight → Underweight | — | $103.18 | $90.66 | -12.1% | -15.1% | +1.1% | -0.0% | +0.3% | -0.3% |
| Nov 5 | BTIG | Maintains | Buy → Buy | — | $103.18 | $90.66 | -12.1% | -15.1% | +1.1% | -0.0% | +0.3% | -0.3% |
| Oct 22 | Canaccord Genuity | Maintains | Hold → Hold | — | $102.69 | $103.49 | +0.8% | +1.3% | -0.8% | -0.1% | +0.1% | -1.9% |
| Oct 13 | BTIG | Maintains | Buy → Buy | — | $94.71 | $94.91 | +0.2% | +0.4% | +3.4% | +1.0% | +0.5% | +2.0% |
| Oct 7 | Evercore ISI | Maintains | In Line → In Line | — | $98.83 | $99.43 | +0.6% | +0.2% | -0.7% | -1.0% | -2.7% | +0.4% |
| Sep 19 | Stifel | Maintains | Buy → Buy | — | $100.21 | $101.15 | +0.9% | -0.1% | +1.6% | -1.4% | -1.3% | -2.0% |
| Aug 8 | UBS | Maintains | Sell → Sell | — | $98.43 | $98.98 | +0.6% | +0.8% | +0.8% | +1.8% | +1.4% | -1.1% |
| Aug 8 | Raymond James | Maintains | Outperform → Outperform | — | $98.43 | $98.98 | +0.6% | +0.8% | +0.8% | +1.8% | +1.4% | -1.1% |
| Aug 8 | RBC Capital | Maintains | Outperform → Outperform | — | $98.43 | $98.98 | +0.6% | +0.8% | +0.8% | +1.8% | +1.4% | -1.1% |
| Jul 8 | Evercore ISI | Maintains | In Line → In Line | — | $92.57 | $92.34 | -0.2% | +1.0% | +1.9% | -0.1% | -1.4% | +0.1% |
| May 12 | Canaccord Genuity | Maintains | Hold → Hold | — | $95.21 | $96.64 | +1.5% | +3.2% | -0.7% | -2.2% | +1.5% | +0.2% |
| May 7 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $92.27 | $92.85 | +0.6% | +2.0% | +1.0% | +0.1% | +3.2% | -0.7% |
| May 6 | Baird | Maintains | Outperform → Outperform | — | $90.48 | $90.48 | +0.0% | +2.0% | +2.0% | +1.0% | +0.1% | +3.2% |
| May 6 | Goldman Sachs | Maintains | Neutral → Neutral | — | $90.48 | $90.48 | +0.0% | +2.0% | +2.0% | +1.0% | +0.1% | +3.2% |
| May 6 | Morgan Stanley | Maintains | Equal Weight → Equal Weight | — | $90.48 | $90.48 | +0.0% | +2.0% | +2.0% | +1.0% | +0.1% | +3.2% |
| May 6 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $90.48 | $90.48 | +0.0% | +2.0% | +2.0% | +1.0% | +0.1% | +3.2% |
| May 6 | Raymond James | Maintains | Outperform → Outperform | — | $90.48 | $90.48 | +0.0% | +2.0% | +2.0% | +1.0% | +0.1% | +3.2% |
| May 6 | JP Morgan | Maintains | Overweight → Overweight | — | $90.48 | $90.48 | +0.0% | +2.0% | +2.0% | +1.0% | +0.1% | +3.2% |
| May 6 | RBC Capital | Maintains | Outperform → Outperform | — | $90.48 | $90.48 | +0.0% | +2.0% | +2.0% | +1.0% | +0.1% | +3.2% |
| May 6 | Stifel | Maintains | Buy → Buy | — | $90.48 | $90.48 | +0.0% | +2.0% | +2.0% | +1.0% | +0.1% | +3.2% |
| Feb 10 | Barclays | Maintains | Underweight → Underweight | — | $100.93 | $101.57 | +0.6% | -0.5% | -1.4% | +0.0% | +0.9% | +0.6% |
| Feb 10 | Truist | Maintains | Hold → Hold | — | $100.93 | $101.57 | +0.6% | -0.5% | -1.4% | +0.0% | +0.9% | +0.6% |
| Feb 7 | Raymond James | Maintains | Outperform → Outperform | — | $102.69 | $102.94 | +0.2% | -1.7% | -0.5% | -1.4% | +0.0% | +0.9% |
| Feb 7 | RBC Capital | Maintains | Outperform → Outperform | — | $102.69 | $102.94 | +0.2% | -1.7% | -0.5% | -1.4% | +0.0% | +0.9% |
| Feb 7 | JMP Securities | Maintains | Market Outperform → Market Outperform | — | $102.69 | $102.94 | +0.2% | -1.7% | -0.5% | -1.4% | +0.0% | +0.9% |
| Feb 7 | Needham | Maintains | Hold → Hold | — | $102.69 | $102.94 | +0.2% | -1.7% | -0.5% | -1.4% | +0.0% | +0.9% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 29, 2026 | Yi Sang | Group President, Asia Pacific | Sell | 800 | $82.66 | $66K | 27,251 | +1.47% | +2.70% |
| May 29, 2026 | Yi Sang | Group President, Asia Pacific | Sell | 4,200 | $82.64 | $347K | 28,051 | +1.47% | +2.70% |
8-K
Zimmer Biomet Holdings, Inc. -- 8-K Filing
May 27
8-K · 5.02
!!! Very High
Zimmer Biomet Holdings, Inc. -- 8-K 5.02: Executive Change
May 12
8-K · 5.02
!!! Very High
Zimmer Biomet Holdings, Inc. -- 8-K 5.02: Executive Change
Zimmer Biomet appointed Suketu Upadhyay as interim CFO and Paul Stellato as principal financial officer while Upadhyay resigned as director, signaling leadership transitions in the orthopedic device company's finance function.
Apr 28
8-K
Zimmer Biomet Holdings, Inc. -- 8-K Filing
Zimmer Biomet reported Q1 2026 financial results with Phipps appointed as Senior Vice President of Chief Legal and Corporate Affairs Officer and Secretary.
Apr 28
8-K · 5.02
!!! Very High
SkinHealth Systems Inc. -- 8-K 5.02: Executive Change
SkinHealth Systems appointed Kenneth Tripp as director and Dr. Sachin Shridharani as Senior Vice President, signaling management strengthening under new leadership.
Apr 22
8-K
Zimmer Biomet Holdings, Inc. -- 8-K Filing
Zimmer Biomet reported full-year 2025 financial results, providing investors with updated performance metrics and operational guidance for the orthopedic device manufacturer.
Feb 10
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Dodge & Cox | 23,542,700 | $2.1B | — | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 12,793,412 | $1.2B | New | Mar 2026 |
| 3 | Vanguard Portfolio Management Llc | 8,650,228 | $782M | New | Mar 2026 |
| 4 | Franklin Resources Inc | 5,452,665 | $493M | Reduced | Mar 2026 |
| 5 | Primecap Management Co/ca/ | 3,907,150 | $353M | Reduced | Mar 2026 |
| 6 | Morgan Stanley | 3,676,192 | $331M | Added | Dec 2025 |
| 7 | Invesco Ltd. | 3,605,425 | $326M | Added | Mar 2026 |
| 8 | Northern Trust Corp | 2,023,067 | $183M | Reduced | Mar 2026 |
| 9 | Equity Investment Corp | 1,744,304 | $158M | Added | Mar 2026 |
| 10 | Bank Of America Corp /de/ | 1,549,790 | $140M | Added | Mar 2026 |
| 11 | Citadel Advisors Llc | 1,378,665 | $125M | Added | Mar 2026 |
| 12 | Ubs Group Ag | 1,373,365 | $124M | Added | Mar 2026 |
| 13 | Bank Of New York Mellon Corp | 1,214,337 | $110M | Reduced | Mar 2026 |
| 14 | Victory Capital Management Inc | 1,139,894 | $103M | Reduced | Mar 2026 |
| 15 | Arrowstreet Capital, Limited Partnership | 1,104,218 | $100M | Added | Mar 2026 |
| 16 | Nuveen, Llc | 999,912 | $90M | Reduced | Mar 2026 |
| 17 | Jpmorgan Chase & Co | 828,420 | $73M | Added | Mar 2026 |
| 18 | Causeway Capital Management Llc | 808,110 | $73M | Added | Mar 2026 |
| 19 | Raymond James Financial Inc | 763,201 | $69M | Added | Mar 2026 |
| 20 | Pacer Advisors, Inc. | 697,753 | $63M | Added | Dec 2025 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$17.32B
Enterprise Value
$23.66B
P/E (TTM)
24.55x
Forward P/E
10.28x
PEG Ratio
-1.26x
P/B
1.36x
P/S
2.10x
P/FCF
11.76x
EV/EBITDA
10.67x
Shares Out
198.7M
Financials (TTM)
Revenue
$8.23B
Net Income
$705.2M
EBITDA
$2.22B
Free Cash Flow
$1.47B
Op Cash Flow
$1.70B
EPS Basic
$3.56
EPS Diluted
$3.55
EPS Forward
$8.48
Gross Margin
61.6%
Op Margin
16.6%
Net Margin
8.6%
Balance Sheet
Total Assets
$23.09B
Total Liab.
$10.39B
Total Equity
$12.71B
Cash
$591.9M
LT Debt
$6.93B
Book Value/Sh
$64.17
Debt/Equity
0.59x
Current Ratio
1.98
Quick Ratio
1.10
Returns & Growth
ROE
5.5%
ROA
3.0%
ROIC
5.5%
Rev Growth YoY
+7.2%
EPS Growth YoY
-20.0%
Price Returns
2W
-0.4%
1M
-0.1%
3M
-16.4%
6M
-15.6%
12M
-10.7%
Technicals
52W High
$107.71
52W Low
$79.58
50d MA
$87.15
200d MA
$92.60
RSI (14)
68.00
ATR (14)
$2.12
Beta
0.61
Avg Volume
2.2M
Dividends
Div Rate
$0.96
Div Yield
1.2%
Frequency
4
Ex-Div Date
Mar 31, 2026
Analyst Price Targets
Consensus
$97.90
High
$120.00
Low
$83.00
Median
$93.50
Data updated apr 27, 2026 11:32am
· Source: financialmodelingprep.com